Advanced search
Publication Cover
Modern Rheumatology Volume 23, 2013 - Issue 6
Journal homepage
87
Views
23
CrossRef citations to date
0
Altmetric
Original Articles

Serum chemokine levels as prognostic markers in patients with early systemic sclerosis: a multicenter, prospective, observational study

Minoru HasegawaDepartment of Dermatology, School of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1 Takaramachi, Kanazawa, Ishikawa 920-8641, JapanCorrespondence[email protected]
,
Yoshihide AsanoDepartment of Dermatology, University of Tokyo Graduate School of Medicine, Tokyo, Japan
,
Hirahito EndoDepartment of Internal Medicine (Omori), Toho University School of Medicine, Tokyo, Japan
,
Manabu FujimotoDepartment of Dermatology, School of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1 Takaramachi, Kanazawa, Ishikawa 920-8641, Japan
,
Daisuke GotoDepartment of Rheumatology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
,
Hironobu IhnDepartment of Dermatology and Plastic Surgery School of Life Sciences, Kumamoto University, Kumamoto, Japan
,
Katsumi InoueDivision of Rehabilitation Science, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
,
Osamu IshikawaDepartment of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Japan
,
Yasushi KawaguchiInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan
,
Masataka KuwanaDivision of Rheumatology Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan
,
Fumihide OgawaDepartment of Dermatology, Nagasaki University Graduate School of Biomedical Science, Nagasaki, Japan
,
Hiroki TakahashiFirst Department of Internal Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan
,
Sumiaki TanakaDepartment of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Sagamihara, Japan
,
Shinichi SatoDepartment of Dermatology, University of Tokyo Graduate School of Medicine, Tokyo, Japan
&
Kazuhiko TakeharaDepartment of Dermatology, School of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1 Takaramachi, Kanazawa, Ishikawa 920-8641, Japan
 show all
Pages 1076-1084 | Received 08 Aug 2012, Accepted 27 Oct 2012, Published online: 14 Jan 2014

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Akira Utsunomiya, Minoru Hasegawa, Noritaka Oyama, Yoshihide Asano, Hirahito Endo, Manabu Fujimoto, Daisuke Goto, Osamu Ishikawa, Yasushi Kawaguchi, Masataka Kuwana, Fumihide Ogawa, Hiroki Takahashi, Sumiaki Tanaka, Shinichi Sato, Kazuhiko Takehara & Hironobu Ihn. (2021) Clinical course of Japanese patients with early systemic sclerosis: A multicenter, prospective, observational study. Modern Rheumatology 31:1, pages 162-170.
Read now
Maurizio Cutolo, Stefano Soldano & Vanessa Smith. (2019) Pathophysiology of systemic sclerosis: current understanding and new insights. Expert Review of Clinical Immunology 15:7, pages 753-764.
Read now
Yoshihito Shima, Yasushi Kawaguchi & Masataka Kuwana. (2019) Add-on tocilizumab versus conventional treatment for systemic sclerosis, and cytokine analysis to identify an endotype to tocilizumab therapy. Modern Rheumatology 29:1, pages 134-139.
Read now
Patrizia Fuschiotti. (2016) Current perspectives on the immunopathogenesis of systemic sclerosis. ImmunoTargets and Therapy 5, pages 21-35.
Read now

Articles from other publishers (19)

José E. Oller-Rodríguez, Elvira Vicens Bernabeu, Roxana Gonzalez-Mazarío, Elena Grau García, Francisco M. Ortiz Sanjuan & José A. Román Ivorra. (2022) Utility of cytokines CXCL4, CXCL8 and GDF15 as biomarkers in systemic sclerosis. Medicina Clínica 159:8, pages 359-365.
Crossref
José E. Oller-Rodríguez, Elvira Vicens Bernabeu, Roxana Gonzalez-Mazarío, Elena Grau García, Francisco M. Ortiz Sanjuan & José A. Román Ivorra. (2022) Utility of cytokines CXCL4, CXCL8 and GDF15 as biomarkers in systemic sclerosis. Medicina Clínica (English Edition) 159:8, pages 359-365.
Crossref
Tetsuya Ikawa, Takuya Miyagawa, Yuki Fukui, Shun Minatsuki, Hisataka Maki, Toshiro Inaba, Masaru Hatano, Satoshi Toyama, Jun Omatsu, Kentaro Awaji, Yuta Norimatsu, Yusuke Watanabe, Ayumi Yoshizaki, Shinichi Sato & Yoshihide Asano. (2021) Association of serum CCL20 levels with pulmonary vascular involvement and primary biliary cholangitis in patients with systemic sclerosis. International Journal of Rheumatic Diseases 24:5, pages 711-718.
Crossref
Shuichi Shimada, Katsunari Makino, Masatoshi Jinnin, Soichiro Sawamura, Yuya Kawano, Maho Ide, Ikko Kajihara, Takamitsu Makino, Satoshi Fukushima & Hironobu Ihn. (2020) CXCL17-mediated downregulation of type I collagen via MMP1 and miR-29 in skin fibroblasts possibly contributes to the fibrosis in systemic sclerosis. Journal of Dermatological Science 100:3, pages 183-191.
Crossref
Meghan H. Pearl, Lucia Chen, Rim ElChaki, David Elashoff, David W. Gjertson, Maura Rossetti, Patricia L. Weng, Qiuheng Zhang, Elaine F. Reed & Eileen Tsai Chambers. (2020) Endothelin Type A Receptor Antibodies Are Associated With Angiotensin II Type 1 Receptor Antibodies, Vascular Inflammation, and Decline in Renal Function in Pediatric Kidney Transplantation. Kidney International Reports 5:11, pages 1925-1936.
Crossref
Amin M. Cheikhi, Zariel I. Johnson, Dana R. Julian, Sarah Wheeler, Carol Feghali-Bostwick, Yvette P. Conley, James Lyons-Weiler & Cecelia C. Yates. (2020) Prediction of severity and subtype of fibrosing disease using model informed by inflammation and extracellular matrix gene index. PLOS ONE 15:10, pages e0240986.
Crossref
Akira Utsunomiya, Noritaka Oyama & Minoru Hasegawa. (2020) Potential Biomarkers in Systemic Sclerosis: A Literature Review and Update. Journal of Clinical Medicine 9:11, pages 3388.
Crossref
Yoshihide Asano & John Varga. (2020) Rationally-based therapeutic disease modification in systemic sclerosis: Novel strategies. Seminars in Cell & Developmental Biology 101, pages 146-160.
Crossref
Adi Mor, Michal Segal Salto, Avi Katav, Neta Barashi, Victoria Edelshtein, Mirko Manetti, Yair Levi, Jacob George & Marco Matucci-Cerinic. (2019) Blockade of CCL24 with a monoclonal antibody ameliorates experimental dermal and pulmonary fibrosis. Annals of the Rheumatic Diseases 78:9, pages 1260-1268.
Crossref
Yan-hong Sun, Meng Xie, Shi-di Wu, Jing Zhang & Chang-zheng Huang. (2019) Identification and Interaction Analysis of Key Genes and MicroRNAs in Systemic Sclerosis by Bioinformatics Approaches. Current Medical Science 39:4, pages 645-652.
Crossref
Jamie King, David Abraham & Richard Stratton. (2018) Chemokines in systemic sclerosis. Immunology Letters 195, pages 68-75.
Crossref
Andréa Tavares Dantas, Anderson Rodrigues de Almeida, Maria Clara Pinheiro Duarte Sampaio, Marina Ferraz Cordeiro, Laurindo Ferreira da Rocha Jr, Priscilla Stela Santana de Oliveira, Michelly Cristiny Pereira, Moacyr Jesus Barreto de Melo Rego, Claudia Diniz Lopes Marques, Ivan da Rocha Pitta, Angela Luzia Branco Pinto Duarte & Maira Galdino da Rocha Pitta. (2017) Corticosteroid inhibits chemokines production in systemic sclerosis patients. Steroids 127, pages 24-30.
Crossref
Silvia Bellando Randone, Jacob George, Celestina Mazzotta, Serena Guiducci, Daniel E. Furst, Adi Mor & Marco Matucci Cerinic. (2016) Angiostatic and Angiogenic Chemokines in Systemic Sclerosis: An Overview. Journal of Scleroderma and Related Disorders 2:1, pages 1-10.
Crossref
Francesco Boin & Carlo Chizzolini. 2017. Scleroderma. Scleroderma 161 195 .
Minoru Hasegawa. (2016) Biomarkers in systemic sclerosis: Their potential to predict clinical courses. The Journal of Dermatology 43:1, pages 29-38.
Crossref
Yannick Allanore, Robert Simms, Oliver Distler, Maria Trojanowska, Janet Pope, Christopher P. Denton & John Varga. (2015) Systemic sclerosis. Nature Reviews Disease Primers 1:1.
Crossref
Angelo De Lauretis & Elisabetta A. Renzoni. (2014) Molecular Biomarkers in Interstitial Lung Diseases. Molecular Diagnosis & Therapy 18:5, pages 505-522.
Crossref
Michaela D. Filiou, Ahmed Shamsul Arefin, Pablo Moscato & Manuel B. Graeber. (2014) ‘Neuroinflammation’ differs categorically from inflammation: transcriptomes of Alzheimer's disease, Parkinson's disease, schizophrenia and inflammatory diseases compared. neurogenetics 15:3, pages 201-212.
Crossref
Minoru Hasegawa, Yoshihide Asano, Hirahito Endo, Manabu Fujimoto, Daisuke Goto, Hironobu Ihn, Katsumi Inoue, Osamu Ishikawa, Yasushi Kawaguchi, Masataka Kuwana, Fumihide Ogawa, Hiroki Takahashi, Sumiaki Tanaka, Shinichi Sato & Kazuhiko Takehara. (2014) Serum Adhesion Molecule Levels as Prognostic Markers in Patients with Early Systemic Sclerosis: A Multicentre, Prospective, Observational Study. PLoS ONE 9:2, pages e88150.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.